Martin C. Tom, M.D.

Peer-Reviewed Articles

1. Kotecha, R, Chiang, V, Tom, MC, Parent, EE, Nabavizadeh, SA, Siegel, BA, Huang, J, Zan, E, Peddi, S, Brem, S, Ware, M, Sulman, EP, Kesari, S, Pope, WB, Holmes, R, Chau, A, Teoh, EJ, Chao, ST, Aboian, M, Barbaro, M, Chundru, S, Fogelson, S, Goyal, MS, Kim, AH, Kondziolka, D, Kurtz, G, Lokuta, M, Mehta, MP, Miller, MP, Odia, Y, Ponisio, MR, Weick, S. 18F-Fluciclovine for Detection of Recurrent Brain Metastases After Radiation Therapy: Image Interpretation Criteria and Diagnostic Performance From the PURSUE Study. International Journal of Radiation Oncology Biology Physics 125(5):1410-1420, 2026. e-Pub 2026. PMID: 41759680.
2. Tom, MC, Haisraely, O, Perni, S, Kudchadker, RJ, Prajapati, S, Zlateva, Y, Weinberg, JS, Yeboa, DN, Li, J, Ferguson, SD, Alvarez-Breckenridge, C, Patel, CB, Ene, CI, Prabhu, S, Beckham, TH. Cs-131 Collagen Tile Brachytherapy for Recurrent Glioblastoma: Treatment Outcomes and Toxicity. Practical Radiation Oncology 16(2):e101-e107, 2026. e-Pub 2026. PMID: 41360286.
3. Beckham, TH, Dudzinski, SO, Rooney, M, Faraj, CA, Pasli, M, Perni, S, Tom, MC, Ghia, AJ, Yeboa, DN, McAleer, MF, Swanson, T, McGovern, SL, Wang, C, Chung, C, De, BS, Jiang, W, Kim, BY, Ferguson, SD, Tawbi, H, Glitza, I, Le, X, Kaya, D, Dumbrava, EE, Briere, TM, Mackin, DS, Li, J. Incorporating an NCCN-Based Systemic Therapy CNS Activity Score Into SRS Decision-Making for Patients With 5 or More Brain Metastases. JNCCN 24(2):34-40, 2026. e-Pub 2026. PMID: 41671425.
4. Mackin, DS, Cifter, G, Zlateva, Y, Wang, J, Ding, Y, ul Hassan, MS, Wang, Z, Diagaradjane, P, Guan, F, Salzillo, TC, Krafft, SP, Li, J, Tom, MC, Ghia, AJ, Briere, TM. Clinical Workflow of Spine Stereotactic Radiotherapy and Radiosurgery: Insights from a Single-Institution Physics Perspective. Cancers 18(3), 2026. e-Pub 2026. PMID: 41681825.
5. Kleber, T, Milton, D, Srinivasan, S, Panthi, B, Floyd, W, Goethe, E, Davies, MA, Tawbi, H, Glitza, IC, Kaya, D, Li, J, Swanson, T, Perni, S, Tom, MC, Wang, C, Prabhu, SS, Weinberg, J, McCutcheon, IE, Chung, C, Ferguson, SD, Beckham, TH. Outcomes of Patients with Melanoma Brain Metastases Treated with Ipilimumab and Nivolumab with or without Upfront Comprehensive Stereotactic Radiosurgery. Neuro-Oncology Advances 8(1), 2026. e-Pub 2026. PMID: 41664820.
6. Yeboa, DN, Whitfield, BT, Lin, R, Ejezie, CL, Swanson, T, Beckham, TH, Wang, C, De, BS, Perni, S, Tom, MC, Li, J, McGovern, SL, Harrison, R, Majd, NK, Puduvalli, VK, Aaroe, AE, Loghin, ME, O'Brien, BJ, Patel, AD, Patel, C, Wefel, JS, Taslicay, CA, Gule-Monroe, MK, Paulino, AC, McAleer, MF, Grosshans, DR, Ghia, AJ, Jiang, W, Chung, C, Maor, MM, Yang, CH, Gubbiotti, M, Kamiya Matsuoka, C, Ballester, L, Weathers, S, Huse, J. Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses. Journal of neuro-oncology 176(1), 2026. e-Pub 2026. PMID: 41191157.
7. Tom, MC, Ghia, AJ. Stereotactic Body Radiation Therapy for Epidural Spinal Cord Compression: Treat Aggressively Now, Avoid Recurrence Later. International Journal of Radiation Oncology Biology Physics 123(2):330, 2025. e-Pub 2025. PMID: 40914570.
8. Haisraely, O, Tom, MC. Beneath the Surface: Peeling Back Layers of Management Complexity for Leptomeningeal Disease From EGFR-mutant Lung Cancer. International Journal of Radiation Oncology Biology Physics 122(5):1082-1083, 2025. e-Pub 2025. PMID: 40675672.
9. Ding, Y, Salzillo, TC, Yeboa, DN, Tom, MC, Wang, Z, Diagaradjane, P, Subashi, ED, Yang, J, Swanson, T, Beckham, TH, Wang, C, Ghia, AJ, Briere, TM, Wang, J, Lathuilière, F, Cloake, S, Han, EY. Optimizing Motion Management and Baseline Shifts in Magnetic Resonance-Guided Spine Stereotactic Body Radiation Therapy. Cancers 17(16), 2025. e-Pub 2025. PMID: 40867326.
10. Haisraely O, Vedala S, Al-Sharfeen A, Manzar GS, Perni S, Tom MC, Beckham TH, Wang C, Yeboa DN, Chung C, McAleer MF, Ghia AJ, Ene CI, Weathers SP, McGovern SL, Wogan CF, Roth M, Li J, De B. Glioblastoma in young adult patients: contemporary patterns of care and survival in the United States. J Neurooncol, 2025. e-Pub 2025. PMID: 40663309.
11. Ghia AJ, Guha-Thakurta N, Munsell MF, Briere TM, Wang C, Beckham TH, Yeboa D, Tom MC, Perni S, Li J, McAleer M, Chang EL, North RY, Alvarez-Breckinridge C, Tatsui CE, Brown PD, Rhines LD. Long-term results from a Phase 1 study of spinal cord constraint relaxation with single session spine stereotactic radiosurgery in the primary management of patients with inoperable, previously unirradiated spinal metastases with epidural extension. Int J Radiat Oncol Biol Phys 124(5):1219-1225, 2025. e-Pub 2025. PMID: 40614786.
12. Andrade-Almeida, RA, Call-Orellana, F, Zuluaga-Garcia, JP, Ramirez-Ferrer, E, Kimchi, G, De, BS, Guimaraes, AB, Alvarez-Breckenridge, C, Li, J, Ghia, AJ, Rhines, LD, Tom, MC, Wang, C, Beckham, TH, Amini, B, North, RY, Tatsui, CE. Local Control After Adjuvant Radiosurgery for Spinal Metastasis Treated With Decompression and Posterior Segmental Stabilization. Advances in Radiation Oncology 10(7), 2025. e-Pub 2025. PMID: 40548160.
13. Beckham TH, Cha EE, Rooney MK, Tom MC, Perni S, McAleer MF, Li J, Kudchadker RJ, Prajapati S, Zlateva Y, Kaya D, Ene CI, Ferguson SD, Huse JT, Prabhu SS, Weinberg JS. Cesium-131 collagen tile brachytherapy for salvage of recurrent intracranial metastases. J Neurooncol, 2025. e-Pub 2025. PMID: 40549120.
14. Goethe EA, Andrade de Almeida RA, Call-Orellana F, Mikula AL, Clarke MJ, Merrell KW, Rose PS, Karim SM, Linzey JR, Szerlip NJ, Amini B, Beckham TH, Ghia AJ, Li J, Tom MC, McAleer MF, Perni S, Wang C, Yeboa DN, Price A, Alvarez-Breckenridge C, Rhines LD, Tatsui CE, North RY. Sacral fracture risk after stereotactic spinal radiosurgery: a multi-institution, retrospective analysis. J Neurosurg Spine:1-8, 2025. e-Pub 2025. PMID: 40540799.
15. Yeboa, DN, Li, J, Lin, R, Prabhu, SS, Beckham, TH, Woodhouse, KD, Swanson, T, Weinberg, J, Wang, X, Chi, X, Ejezie, CL, Suki, D, Wang, C, Ene, CI, McCutcheon, IE, McGovern, SL, McAleer, MF, Tom, MC, Ghia, AJ, Perni, S, Jiang, W, De, BS, Chung, C, Kim, BY, O'Brien, BJ, Huse, J, Wefel, JS, Court, LE, Tawbi, H, Janku, F, Guha-Thakurta, N, Debnam, JM, Johnson, JM, Taslicay, CA, Alvarez-Breckenridge, C, Raza, SM, Heimberger, AB, DeMonte, F, North, RY, Briere, TM, de Groot, JF, Sawaya, RE, Grosshans, DR, Lang Jr, FF, Rao, G, Ferguson, SD. Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy. JAMA Oncology 11(8):890-899, 2025. e-Pub 2025. PMID: 40531511.
16. Ramirez Ferrer E, Kimchi G, Tom MC, Chakravarthy VB, Amini B, Andrade de Almeida RA, Zuluaga-Garcia JP, Call-Orellana F, North RY, Alvarez-Breckenridge CA, Rhines LD, Tatsui CE. Intraoperative ultrasound imaging features in high-grade metastatic spinal cord compression treated with separation surgery. Neurosurg Focus 58(5):E8, 2025. e-Pub 2025. PMID: 40311208.
17. Chuong MD, Mittauer KE, Bassetti MF, Rojas C, Glide-Hurst C, Kalman NS, Tom MC, Rubens M, Crosby J, Burr A, Tolakanahalli R, Gutierrez AN, Bassiri N, Mehta MP, Kotecha R. Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction: A Multicenter, Single-Arm, Phase 2 Trial. Int J Radiat Oncol Biol Phys 122(4):957-967, 2025. e-Pub 2025. PMID: 40158734.
18. Zhang B, Shah KB, Parma M, Wang K, Singhi EK, Lewis W, Rivera M, Altan M, Pozadzides J, Le X, Vokes N, Fossella F, O'Brien B, Wang C, Tom MC, Beckham T, Swanson T, Bronk J, Lin SH, Vega MF, Jacome J, Halliday A, Negrao M, Zhang J, Gibbons DL, Heymach JV, Byers LA, Gay CM. Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC-A Real-World Case Series: Case Report. J Thorac Oncol, 2025. e-Pub 2025. PMID: 40126456.
19. Matsui JK, Swanson D, Allen P, Perlow HK, Bradshaw J, Beckham TH, Tom MC, Wang C, Perni S, Yeboa DN, Ghia AJ, McAleer MF, Li J, Palmer JD, McGovern SL. Reduced Treatment Volumes for Glioblastoma Associated With Lower Rates of Radionecrosis and Lymphopenia: A Pooled Analysis. Adv Radiat Oncol 10(3):101717, 2025. e-Pub 2025. PMID: 40028224.
20. Perlow HK, Raleigh DR, Wang TJC, Pollom EL, Milano MT, Breen WG, Detsky J, Chang EL, Tom MC, Shiue KR, Lehrer EJ, Saeed H, Pike LRG, Lo SS, Mishra MV, Knisely JPS, Chao ST, Sahgal A, Palmer JD. Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected Meningiomas. Int J Radiat Oncol Biol Phys 122(1):150-158, 2024. e-Pub 2024. PMID: 39701546.
21. Tom MC, Nagpal S, Palmer JD, Breen WG, Pollom EL, Lehrer EJ, McGranahan TM, Shiue K, Chundury A, McClelland Iii S, Saeed H, Chang EL, Chiang VLS, Wang TJC, Knisely JPS, Chao ST, Milano MT. An update to the American Radium Society's appropriate use criteria of lower grade gliomas: Integration of IDH inhibitors. Radiother Oncol 202:110640, 2024. e-Pub 2024. PMID: 39557126.
22. Tom MC, Komatineni S, Wang C, de Almeida RAA, Ghia AJ, Beckham TH, Perni S, McAleer MF, Swanson T, Yeboa DN, De BS, Rooney MK, Bishop AJ, Reddy JP, Yang Y, Ludmir EB, Zhang S, Amini B, Alvarez-Breckenridge C, North RY, Rhines LD, Li J, Tatsui CE. Spinal laser interstitial thermal therapy and radiotherapy for thoracic metastatic epidural spinal cord compression. J Neurooncol 170(2):289-296, 2024. e-Pub 2024. PMID: 39325339.
23. Beckham TH, Rooney MK, Cifter G, Bernard V, McAleer MF, De BS, Tom MC, Perni S, Wang C, Swanson T, Tatsui CE, Alvarez-Breckenridge C, North R, Rhines LD, Tang C, Logothetis C, Amini B, Li J, Yeboa DN, Ghia AJ. Stereotactic radiosurgery for prostate cancer spine metastases: local control and fracture risk using a simultaneous integrated boost approach. J Neurosurg Spine 41(3):436-444, 2024. e-Pub 2024. PMID: 38875722.
24. McClelland S 3rd, Tom MC, Milano MT. The Cost of Progression-Free Survival in Treating Low-Grade Glioma. Am J Clin Oncol 48(2):55-56, 2024. e-Pub 2024. PMID: 39145485.
25. Nagpal S, Milano MT, Chiang VL, Soltys SG, Brackett A, Halasz LM, Garg AK, Sahgal A, Ahluwalia MS, Tom MC, Palmer JD, Knisley JPS, Chao ST, Gephart MH, Wang TJC, Lo SS, Chang EL. Executive Summary of the American Radium Society Appropriate Use Criteria for Brain Metastases in EGFR-mutated and ALK-fusion Non-Small Cell Lung Cancer. Neuro Oncol 26(7):1195-1212, 2024. e-Pub 2024. PMID: 38459978.
26. Wang, C, Rooney, MK, Alvarez-Breckenridge, C, Beckham, TH, Chung, C, De, BS, Ghia, AJ, Grosshans, DR, Majd, NK, McAleer, MF, McGovern, SL, North, RY, Paulino, AC, Perni, S, Reddy, JP, Rhines, LD, Swanson, T, Tatsui, CE, Tom, MC, Yeboa, DN, Li, J. Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era—A Population-Based Observational Study. Cancers 16(11), 2024. e-Pub 2024. PMID: 38893133.
27. Beckham, TH, Dudzinski, SO, Pasli, M, Perni, S, Tom, MC, Ghia, AJ, Yeboa, DN, McAleer, MF, Swanson, T, McGovern, SL, Wang, C, Chung, C, Briere, TM, An, R, De, BS, Glitza, IC, Kim, YB, McCutcheon, IE, Ferguson, SD, Li, J. Radiosurgery to 5 or more newly diagnosed brain metastases in the systemic therapy era. Journal of Clinical Oncology 42(16):2026, 2024. e-Pub 2024.
28. Beckham TH, Rooney MK, McAleer MF, Ghia AJ, Tom MC, Perni S, McGovern S, Grosshans D, Chung C, Wang C, De B, Swanson T, Paulino A, Jiang W, Ferguson S, Patel CB, Li J, Yeboa DN. Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches. Neurooncol Pract 11(3):266-274, 2024. e-Pub 2024. PMID: 38737610.
29. Ene CI, Abi Faraj C, Beckham TH, Weinberg JS, Andersen CR, Haider AS, Rao G, Ferguson SD, Alvarez-Brenkenridge CA, Kim BYS, Heimberger AB, McCutcheon IE, Prabhu SS, Wang CM, Ghia AJ, McGovern SL, Chung C, McAleer MF, Tom MC, Perni S, Swanson TA, Yeboa DN, Briere TM, Huse JT, Fuller GN, Lang FF, Li J, Suki D, Sawaya RE. Response of treatment-naive brain metastases to stereotactic radiosurgery. Nat Commun 15(1):3728, 2024. e-Pub 2024. PMID: 38697991.
30. de Almeida RAA, Ghia AJ, Amini B, Wang C, Alvarez-Breckenridge CA, Li J, Rhines LD, Tom MC, North RY, Beckham TH, Tatsui CE. Quantification of MRI Artifacts in Carbon Fiber Reinforced Polyetheretherketone Thoracolumbar Pedicle Screw Constructs prior to Spinal Stereotactic Radiosurgery. Pract Radiat Oncol 14(2):103-111, 2024. e-Pub 2024. PMID: 37914081.
31. Gubbiotti MA, Weinberg JS, Weathers SP, Dasgupta P, Tom MC, Aldape K, Quezado M, Abdullaev Z, Huse JT, Ballester LY. An incidental finding of a high-grade glioma with pleomorphic and pseudopapillary features (HPAP) with PBRM1 mutation. J Neuropathol Exp Neurol 83(2):139-141, 2024. e-Pub 2024. PMID: 38164987.
32. Shanbhag NM, Tom MC, Duncan A, Bin Sumaida A. Impact of Clinical Examination and Gamma Knife Surgery in Stage IV Breast Cancer With Brain Metastasis. Cureus 16(1):e51831, 2024. e-Pub 2024. PMID: 38196988.
33. Lee YC, Wieczorek DJ, Chaswal V, Kotecha R, Hall MD, Tom MC, Mehta MP, McDermott MW, Gutierrez AN, Tolakanahalli R. A study on inter-planner plan quality variability using a manual planning- or Lightning dose optimizer-approach for single brain lesions treated with the Gamma Knife® Icon™. J Appl Clin Med Phys 24(11):e14088, 2023. e-Pub 2023. PMID: 37415385.
34. Sherry AD, Maroongroge S, De B, Amini B, Conley AP, Bishop AJ, Wang C, Beckham T, Tom M, Briere T, Li J, Yeboa DN, McAleer MF, North R, Tatsui CE, Rhines LD, Ghia AJ. Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery. J Neurooncol 164(2):377-386, 2023. e-Pub 2023. PMID: 37667065.
35. Tom MC, DiFilippo FP, Jones SE, Suh JH, Obuchowski NA, Smile TD, Murphy ES, Yu JS, Barnett GH, Angelov L, Mohammadi AM, Huang SS, Wu G, Johnson S, Peereboom DM, Stevens GHJ, Ahluwalia MS, Chao ST. 18F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study. J Neurooncol 163(3):647-655, 2023. e-Pub 2023. PMID: 37341842.
36. Tolakanahalli R, Wieczorek DJJ, Lee YC, Tom MC, Hall MD, McDermott MW, Mehta MP, Kotecha R, Gutierrez AN. OptImal Gamma kNife lIghTnIng sOlutioN (IGNITION) score to characterize the solution space of the Gamma Knife FIP optimizer for stereotactic radiosurgery. J Appl Clin Med Phys 24(6):e13936, 2023. e-Pub 2023. PMID: 36855958.
37. La Rosa A, Wieczorek DJJ, Tolakanahalli R, Lee YC, Kutuk T, Tom MC, Hall MD, McDermott MW, Mehta MP, Gutierrez AN, Kotecha R. Dosimetric Impact of Lesion Number, Size, and Volume on Mean Brain Dose with Stereotactic Radiosurgery for Multiple Brain Metastases. Cancers (Basel) 15(3), 2023. e-Pub 2023. PMID: 36765738.
38. Black AK, Tom MC. Collateral Vascularization in Chronic Superior Vena Cava Syndrome. Mayo Clin Proc 98(2):348-349, 2023. e-Pub 2023. PMID: 36737124.
39. Tewari S, Tom MC, Park DYJ, Wei W, Chao ST, Yu JS, Suh JH, Kilic S, Peereboom DM, Stevens GHJ, Lathia JD, Prayson R, Barnett GH, Angelov L, Mohammadi AM, Ahluwalia MS, Murphy ES. Sex-Specific Differences in Low-Grade Glioma Presentation and Outcome. Int J Radiat Oncol Biol Phys 114(2):283-292, 2022. e-Pub 2022. PMID: 35667529.
40. Kutuk T, Abrams KJ, Tom MC, Rubens M, Appel H, Sidani C, Hall MD, Tolakanahalli R, Wieczorek DJJ, Gutierrez AN, McDermott MW, Ahluwalia MS, Mehta MP, Kotecha R. Dedicated isotropic 3-D T1 SPACE sequence imaging for radiosurgery planning improves brain metastases detection and reduces the risk of intracranial relapse. Radiother Oncol 173:84-92, 2022. e-Pub 2022. PMID: 35662657.
41. Kutuk T, Kotecha R, Tolakanahalli R, Wieczorek DJJ, Lee YC, Ahluwalia MS, Hall MD, McDermott MW, Appel H, Gutierrez AN, Mehta MP, Tom MC. Zero Setup Margin Mask versus Frame Immobilization during Gamma Knife® Icon™ Stereotactic Radiosurgery for Brain Metastases. Cancers (Basel) 14(14), 2022. e-Pub 2022. PMID: 35884453.
42. Park DY, Tom MC, Chen Y, Tewari S, Ahluwalia MS, Yu JS, Chao ST, Suh JH, Peereboom DM, Stevens GHJ, Barnett GH, Angelov L, Mohammadi A, Hogan T, Kissel C, Lapin B, Schuermeyer I, Parsons MW, Naugle R, Murphy ES. Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomas. J Neurooncol 158(3):341-348, 2022. e-Pub 2022. PMID: 35486307.
43. Kutuk T, Tolakanahalli R, McAllister NC, Hall MD, Tom MC, Rubens M, Appel H, Gutierrez AN, Odia Y, Mohler A, Ahluwalia MS, Mehta MP, Kotecha R. Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results. Cancers (Basel) 14(12), 2022. e-Pub 2022. PMID: 35740612.
44. Campbell SR, Tom MC, Agrawal S, Efstathiou JA, Michalski JM, Abramowitz MC, Pollack A, Spratt DE, Hearn JWD, Stephans KL, Gao T, Li J, Tendulkar RD. Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy. Eur Urol Oncol 5(3):304-313, 2022. e-Pub 2022. PMID: 34016556.
45. Tom MC, Milano MT, Chao ST, Soltys SG, Knisely JPS, Sahgal A, Nagpal S, Lo SS, Jabbari S, Wang TJC, Ahluwalia MS, Simonson M, Palmer JD, Gephart MH, Halasz LM, Garg AK, Chiang VLS, Chang EL. Executive summary of American Radium Society's appropriate use criteria for the postoperative management of lower grade gliomas. Radiother Oncol 170:79-88, 2022. e-Pub 2022. PMID: 35367527.
46. Wieczorek DJ, Kotecha R, Hall MD, Tom MC, Davis S, Ahluwalia MS, McDermott MW, Mehta MP, Gutierrez AN, Tolakanahalli R. Systematic evaluation and plan quality assessment of the Leksell® gamma knife® lightning dose optimizer. Med Dosim 47(1):70-78, 2022. e-Pub 2022. PMID: 34696931.
47. Chuong MD, Bryant JM, Herrera R, McCulloch J, Contreras J, Kotecha R, Romaguera T, Alvarez D, Hall MD, Rubens M, Mehta MP, Kaiser A, Tom M, Gutierrez AN, Mittauer KE. Dose-Escalated Magnetic Resonance Image-Guided Abdominopelvic Reirradiation With Continuous Intrafraction Visualization, Soft Tissue Tracking, and Automatic Beam Gating. Adv Radiat Oncol 7(2):100840, 2022. e-Pub 2022. PMID: 35146215.
48. Kotecha R, Tonse R, Menendez MAR, Williams A, Diaz Z, Tom MC, Hall MD, Mehta MP, Alvarez R, Siomin V, Odia Y, Ahluwalia MS, McDermott MW. Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases. Sci Rep 12(1):4567, 2022. e-Pub 2022. PMID: 35296750.
49. Park DY, Tom MC, Wei W, Tewari S, Ahluwalia MS, Yu JS, Chao ST, Suh JH, Peereboom D, Stevens GHJ, Barnett GH, Angelov L, Mohammadi AM, Hogan T, Kissel C, Lapin B, Schuermeyer I, Parsons MW, Naugle R, Murphy ES. Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade glioma. J Neurooncol 156(3):499-507, 2022. e-Pub 2022. PMID: 35064450.
50. Smile TD, Tom MC, Halima A, Ciezki JP, Reddy CA, Stephans KL, Mian OY, Zhang RX, Klein EA, Campbell S, Ulchaker J, Angermeier K K, Tendulkar RD. 125I Interstitial brachytherapy with or without androgen deprivation therapy among unfavorable-intermediate and high-risk prostate cancer. Brachytherapy 21(1):85-93, 2022. e-Pub 2022. PMID: 34656435.
51. Rodriguez LL, Kotecha R, Tom MC, Chuong MD, Contreras JA, Romaguera T, Alvarez D, McCulloch J, Herrera R, Hernandez RJ, Mercado J, Mehta MP, Gutierrez AN, Mittauer KE. CT-guided versus MR-guided radiotherapy: Impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy. Radiother Oncol 166:101-109, 2022. e-Pub 2022. PMID: 34843842.
52. Kutuk T, Tolakanahalli R, Williams A, Tom MC, Vadhan JD, Appel H, Hall MD, Wieczorek DJJ, Davis S, McDermott MW, Ahluwalia MS, Mehta MP, Gutierrez AN, Kotecha R. Impact of MRI timing on tumor volume and anatomic displacement for brain metastases undergoing stereotactic radiosurgery. Neurooncol Pract 8(6):674-683, 2021. e-Pub 2021. PMID: 34777836.
53. Tonse R, Townsend A, Rubens M, Siomin V, McDermott MW, Tom MC, Hall MD, Odia Y, Ahluwalia MS, Mehta MP, Kotecha R. Factors associated with unplanned readmissions and costs following resection of brain metastases in the United States. Sci Rep 11(1):22152, 2021. e-Pub 2021. PMID: 34773051.
54. Tonse R, Rubens M, Appel H, Tom MC, Hall MD, Odia Y, McDermott MW, Ahluwalia MS, Mehta MP, Kotecha R. Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance. Discov Oncol 12(1):48, 2021. e-Pub 2021. PMID: 35201504.
55. Scarborough JA, Tom MC, Kattan MW, Scott JG. Revisiting a Null Hypothesis: Exploring the Parameters of Oligometastasis Treatment. Int J Radiat Oncol Biol Phys 110(2):371-381, 2021. e-Pub 2021. PMID: 33484786.
56. Kotecha R, Tonse R, Rubens M, Appel H, Albrecht F, Kaywin P, Alley EW, Tom MC, Mehta MP. Meta-Analysis of Survival and Development of a Prognostic Nomogram for Malignant Pleural Mesothelioma Treated with Systemic Chemotherapy. Cancers (Basel) 13(9), 2021. e-Pub 2021. PMID: 34063225.
57. Tonse R, Rubens M, Appel H, Tom MC, Hall MD, Odia Y, McDermott MW, Ahluwalia MS, Mehta MP, Kotecha R. Systematic review and meta-analysis of PD-L1 expression discordance between primary tumor and lung cancer brain metastasis. Neurooncol Adv 3(1):vdab166, 2021. e-Pub 2021. PMID: 34988451.
58. Tom MC, Sittenfeld SMC, Shah C, Bauer-Nilsen K, Tendulkar R, Cherian S, Al-Hilli Z, Arthur D, Recht A, Vicini F. Use of a Radiation Tumor Bed Boost After Breast-Conserving Surgery and Whole-Breast Irradiation: Time Trends and Correlates. Int J Radiat Oncol Biol Phys 109(1):273-280, 2021. e-Pub 2021. PMID: 32768561.
59. Kotecha R, Tom MC, Naik M, Angelov L, Benzel EC, Reddy CA, Prayson RA, Kalfas I, Schlenk R, Krishnaney A, Steinmetz MP, Bingaman W, Suh JH, Chao ST. Analyzing the role of adjuvant or salvage radiotherapy for spinal myxopapillary ependymomas. J Neurosurg Spine:1-6, 2020. e-Pub 2020. PMID: 32357340.
60. Obi E, Tom MC, Manyam BV, Grobmyer SR, Al-Hilli Z, Valente S, Fanning A, Radford DM, Cherian S, Tendulkar RD, Shah C. Outcomes with intraoperative radiation therapy for early-stage breast cancer. Breast J 26(3):454-457, 2020. e-Pub 2020. PMID: 31562688.
61. Shah C, Obi E, Tom MC, Manyam BV, Obi B, Al-Hilli Z, Grobmyer S, Abraham J, Xia P, Murray E, Cherian S, Tendulkar RD. Initial outcomes with image-guided partial breast irradiation delivered with intensity-modulated radiation therapy. Breast J 26(2):227-230, 2020. e-Pub 2020. PMID: 31502371.
62. Tom MC, Reddy CA, Smile TD, Zhang RX, Ciezki JP, Stephans KL, Mian OY, Klein EA, Campbell S, Ulchaker J, Angermeier K, Tendulkar RD. Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapy. Brachytherapy 19(1):43-50, 2020. e-Pub 2020. PMID: 31813740.
63. Tom MC, Park DYJ, Yang K, Leyrer CM, Wei W, Jia X, Varra V, Yu JS, Chao ST, Balagamwala EH, Suh JH, Vogelbaum MA, Barnett GH, Prayson RA, Stevens GHJ, Peereboom DM, Ahluwalia MS, Murphy ES. Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma. Int J Radiat Oncol Biol Phys 105(5):1106-1112, 2019. e-Pub 2019. PMID: 31461674.
64. Karimi AM, Tom MC, Manyam BV, Obi E, Tendulkar RD, Cherian S, Fleming C, Suarez E, Naik M, Shah C. Evaluating Improvements in Cardiac Dosimetry in Breast Radiotherapy and Comparison of Cardiac Sparing Techniques. J Radiat Oncol, 2019. e-Pub 2019.
65. Tom MC, Nguyen JK, Lucianò R, Mian OY, Stephans KL, Ciezki JP, Smile TD, Wei W, McKenney JK, Magi-Galluzzi C, Tendulkar RD. Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy. J Urol 202(4):710-716, 2019. e-Pub 2019. PMID: 31059665.
66. Tom MC, Varra V, Leyrer CM, Park DY, Chao ST, Yu JS, Suh JH, Reddy CA, Balagamwala EH, Broughman JR, Kotagal KA, Vogelbaum MA, Barnett GH, Ahluwalia MS, Peereboom DM, Prayson RA, Stevens GHJ, Murphy ES. Risk Factors for Progression Among Low-Grade Gliomas After Gross Total Resection and Initial Observation in the Molecular Era. Int J Radiat Oncol Biol Phys 104(5):1099-1105, 2019. e-Pub 2019. PMID: 31022510.
67. Tom MC, Ross RB, Koyfman SA, Adelstein DJ, Lorenz RR, Burkey BB, Shah C, Suh JH, Bolwell BJ, Savage C, Platz S, Ward MC. Clinical Factors Associated With Cost in Head and Neck Cancer: Implications for a Bundled Payment Model. J Oncol Pract 15(6):e560-e567, 2019. e-Pub 2019. PMID: 31009283.
68. Tom MC, Berriochoa C, Reddy CA, Tendulkar RD. Trends in Radiation Oncology Residency Applicant Interview Experiences and Post-Interview Communication. Int J Radiat Oncol Biol Phys 103(4):818-822, 2019. e-Pub 2019. PMID: 30496876.
69. Varra V, Ross RB, Juloori A, Campbell S, Tom MC, Joshi NP, Woody NM, Ward MC, Xia P, Koyfman SA, Greskovich JF. Selectively sparing the submandibular gland when level Ib lymph nodes are included in the radiation target volume: An initial safety analysis of a novel planning objective. Oral Oncol 89:79-83, 2019. e-Pub 2019. PMID: 30732963.
70. Blandford AD, Bellerive C, Tom M, Koyfman S, Adelstein DJ, Plesec TP, Perry JD, Singh AD. Case Report: Primary Orbital Squamous Cell Carcinoma. Ocul Oncol Pathol 5(1):60-65, 2019. e-Pub 2019. PMID: 30675479.
71. Tom MC, Joshi N, Vicini F, Chang AJ, Hong TS, Showalter TN, Chao ST, Wolden S, Wu AJ, Martin D, Husain Z, Badiyan SN, Kolar M, Sherertz T, Mourtada F, Cohen GN, Shah C. The American Brachytherapy Society consensus statement on intraoperative radiation therapy. Brachytherapy 18(3):242-257, 2019. e-Pub 2019. PMID: 31084904.
72. Tom MC, Hepel JT, Patel R, Kamrava M, Badiyan SN, Cohen GN, Shah C. The American Brachytherapy Society consensus statement for electronic brachytherapy. Brachytherapy 18(3):292-298, 2019. e-Pub 2019. PMID: 30497939.
73. Tom M, Murphy ES. Gray Zone, Expert Opinion: Resection Bed Only. Int J Radiat Oncol Biol Phys 102(3):487-488, 2018. e-Pub 2018. PMID: 30238897.
74. Tom MC, Murphy ES. Gray Zone: Low Grade Glioma, High Stakes Controversy – When and How to Treat in the Molecular Era?. Int J Radiat Oncol Biol Phys 101(3):516-517, 2018. e-Pub 2018. PMID: 29893268.
75. Tom MC, Koay EJ, Bhosale P, Das P, Katz MH, Fleming JB, Lee JE, Varadhachary GR, Wolff RA, Crane CH. Radiation dose escalation to the tumor-arterial interface of locally advanced and borderline resectable pancreatic cancer. Contemporary Radiation Oncology, 2016. e-Pub 2016.
76. Diaz JP, Chirayil R, Chirayil S, Tom M, Head KJ, Luebke KJ. Association of a peptoid ligand with the apical loop of pri-miR-21 inhibits cleavage by Drosha. RNA 20(4):528-39, 2014. e-Pub 2014. PMID: 24497550.

Review Articles

1. Mayo ZS, Halima A, Broughman JR, Smile TD, Tom MC, Murphy ES, Suh JH, Lo SS, Barnett GH, Wu G, Johnson S, Chao ST. Radiation necrosis or tumor progression? A review of the radiographic modalities used in the diagnosis of cerebral radiation necrosis. J Neurooncol 161(1):23-31, 2023. e-Pub 2023. PMID: 36633800.
2. Tonse R, Tom MC, Mehta MP, Ahluwalia MS, Kotecha R. Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases. Cancers (Basel) 13(15), 2021. e-Pub 2021. PMID: 34359583.
3. Kotecha R, Tom MC, Mehta MP. Novel Radiation Approaches. Neurosurg Clin N Am 32(2):211-223, 2021. e-Pub 2021. PMID: 33781503.
4. Tom MC, Cahill DP, Buckner JC, Dietrich J, Parsons MW, Yu JS. Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?. Am Soc Clin Oncol Educ Book 39:133-145, 2019. e-Pub 2019. PMID: 31099638.

Professional Educational Materials

1. Shah C, Tom MC. Breast Brachytherapy: Relevant with the Emergence of IORT?, 2018.
2. Hunter-Ellul L, Tom MC. Resident’s Corner: Prescription Practices Among Texas Dermatologists, 2015.

Editorials

1. Tom, MC, Wang, K, Edwards, D, Huang, J. Electrifying Results? Tumor Treating Fields Reduce Intracranial Relapse of Non-Small Cell Lung Cancer Brain Metastasis Following Radiosurgery in the METIS Trial. International Journal of Radiation Oncology Biology Physics 124(2):294-295, 2026. PMID: 41071147.
2. Breen WG, Kotecha R, Tom MC, Straube C, Pollom EL, Cramer CK, Kim MM, Yang JT. Leptomeningeal Metastasis, an Evolving Frontier for Radiation Oncology. Int J Radiat Oncol Biol Phys 123(3):605-609, 2025. PMID: 40998475.
3. Straube C, Tom MC, Breen WG, Cramer C, Pollom EL, Kim MM. Defining the Role of Radiation Therapy for Central Nervous System Metastases in a Rapidly Evolving Landscape of Novel Therapeutics. Int J Radiat Oncol Biol Phys 121(4):847-850, 2025. PMID: 39988422.
4. Tom MC, Kotecha R. Beating a Benchmark: Boron Neutron Capture Therapy for Recurrent and Refractory Meningiomas. Neuro Oncol 24(1):99-100, 2022. PMID: 34508643.

Book Chapters

1. Alfaifi S, Tom MC, Yu J, Chao ST. Glioblastoma, IDH-Wildtype. In: Essentials of Clinical Radiation Oncology. Third. Demos Medical Publishing, 2025.
2. Vuong W, Tom MC, Suh JH. Brain Metastases. In: Essentials of Clinical Radiation Oncology. Third. Demos Medical Publishing, 2025.
3. Alfaifi S, Parsai S, Yu J, Chao ST, Tom MC. IDH Mutant Gliomas: Grade 3. In: Essentials of Clinical Radiation Oncology. Third. Demos Medical Publishing, 2025.
4. Bommireddy A, Stockham AL, Tom MC, Yu J. Meningioma. In: Essentials of Clinical Radiation Oncology. Third. Demos Medical Publishing, 2025.
5. Ufondu AN, Davies EM, Tom MC, Murphy ES. Low Grade Gliomas. In: Essentials of Clinical Radiation Oncology. Third. Demos Medical Publishing, 2025.
6. Mayo ZS, Smile TD, Tom MC. Craniopharyngioma. In: Essentials of Clinical Radiation Oncology. Third. Demos Medical Publishing, 2025.
7. Alfaifi S, Winter IW, Tom MC, Tendulkar RD, Balagamwala EH. Oligometastatic Disease. In: Essentials of Clinical Radiation Oncology. Third. Demos Medical Publishing, 2025.
8. Rooney MK, Tom MC, Perni S, Yeboa DN. Meningioma. In: Pocket Radiation Oncology. 2. Wolters Kluwer, 2024.
9. Rooney MK, Tom MC, Perni S, Yeboa DN. Low Grade Gliomas. In: Pocket Radiation Oncology. 2. Wolters Kluwer, 2024.
10. Rooney MK, Tom MC, Perni S, Yeboa DN. High Grade Gliomas. In: Pocket Radiation Oncology. 2. Wolters Kluwer, 2024.
11. Rooney MK, Tom MC, Perni S, Yeboa DN. Benign CNS. In: Pocket Radiation Oncology. 2. Wolters Kluwer, 2024.
12. Rooney MK, Tom MC, Perni S, Yeboa DN. Pituitary Adenoma and Craniopharyngioma. In: Pocket Radiation Oncology. 2. Wolters Kluwer, 2024.
13. Tom, MC, Balagamwala, EH, Suh, JH, Chao, ST. Spinal Cord Ependymoma. In: Adult CNS Radiation Oncology: Principles and Practice. Second. Springer Nature Switzerland, 165-175, 2024.
14. Campbell, S, Kotecha, R, Tom, MC, Mehta, MP. Paranasal Sinus Melanoma – Definitive Stereotactic Body Radiation Therapy. In: Radiosurgery of the Skull Base. Elsevier, 39-42, 2023.
15. Tom, MC, Campbell, S, Kotecha, R, Mehta, MP. Occipital Condyle/Clivus/C1 Vertebra Metastasis – Upfront Stereotactic Body Radiation Therapy. In: Radiosurgery of the Skull Base. Elsevier, 233-236, 2023.
16. Campbell, S, Kotecha, R, Tom, MC, Mehta, MP. Chondrosarcoma – Definitive Radiosurgery After Subtotal Resection. In: Radiosurgery of the Skull Base. Elsevier, 107-110, 2023.
17. Tom, MC, Campbell, S, Kotecha, R, Mehta, MP. Chordoma – Immediate Postoperative/Post-Proton Therapy Radiosurgery for Residual Disease. In: Radiosurgery of the Skull Base. Elsevier, 111-114, 2023.
18. Tonse R, Tom MC, Kotecha R. Systemic Therapy and Radiation Therapy in Lung Cancer. In: Lung Cancer Rehabilitation. First. Elsevier, 2022.
19. Tom MC, Murphy ES. Low Grade Gliomas. In: Essentials of Clinical Radiation Oncology. Second. Demos Medical Publishing, 2021.
20. Balagamwala EH, Tom MC, Ahluwalia M, Sharrett J, Chao ST. Radiation Necrosis: A Practical Approach. In: Intracranial and Spinal Radiotherapy. Springer, 2021.
21. Parsai S, Tom MC, Chao ST. Anaplastic Gliomas. In: Essentials of Clinical Radiation Oncology. Second. Demos Medical Publishing, 2021.
22. Tom MC, Schwartz DJ, Stockham AL. Meningioma. In: Essentials of Clinical Radiation Oncology. Second. Demos Medical Publishing, 2021.
23. Tom MC, Marwaha G, Suh JH, Singh AD. Uveal Melanoma. In: Essentials of Clinical Radiation Oncology. Second. Demos Medical Publishing, 2021.
24. Kilic SS, Tom MC, Koyfman SA, Joshi NP. Salivary Gland Tumors. In: Essentials of Clinical Radiation Oncology. Second. Demos Medical Publishing, 2021.
25. Tom MC, Smile TD, Murphy ES. Craniopharyngioma. In: Essentials of Clinical Radiation Oncology. Second. Demos Medical Publishing, 2021.
26. Campbell SR, Tom MC, Suh JH. Brain Metastases. In: Essentials of Clinical Radiation Oncology. Second. Demos Medical Publishing, 2021.
27. Winter IW, Balagamwala EH, Tom MC. Oligometastatic Disease. In: Essentials of Clinical Radiation Oncology. Second. Demos Medical Publishing, 2021.
28. Joshi NP, Tom MC. Skin Cancer. In: Practical Radiation Oncology. Springer, 2020.
29. Joshi NP, Tom MC. Oropharynx Cancer. In: Practical Radiation Oncology. Springer, 2020.
30. Joshi NP, Tom MC. Head and Neck Cancer. In: Hematology-Oncology Board Review. McGraw Hill, 2019.
31. Joshi NP, Tom MC. Nasopharyngeal Carcinoma. In: Hematology-Oncology Board Review. McGraw Hill, 2019.
32. Tom MC, Smile T, Murphy ES. Craniopharyngioma. In: Essentials of Clinical Radiation Oncology. First. Demos Medical Publishing, 2018.
33. Tom MC, Koyfman SA, Joshi NP. Salivary Gland Tumors. In: Essentials of Clinical Radiation Oncology. First. Demos Medical Publishing, 2018.
34. Tom MC, Berriochoa C, Shah C. Recurrent Breast Cancer. In: Essentials of Clinical Radiation Oncology. First. Demos Medical Publishing, 2018.
35. Tom MC, Suh JH, Chao ST. Spinal Cord Ependymoma. In: Adult CNS Radiation Oncology: Principles and Practice. First. Springer Science + Business Media, 2018.
36. Tom MC, Murphy ES. Low Grade Glioma. In: Essentials of Clinical Radiation Oncology. First. Demos Medical Publishing, 2018.

Web Publications

1. Tom MC. A commentary on: WHO Grade 2 IDH-Mutant Astrocytoma in a 28-Year-Old Woman. Elsevier PracticeUpdate Website, 2022.
2. Tom MC. A commentary on: 60-Year-Old Male With Right Parietal Glioblastoma and KPS 80. Elsevier PracticeUpdate Website, 2022.
3. Mehta MP, Kotecha RR, Tom MC. A commentary on: Strategies to Preserve Neurocognition in Patients With Primary Gliomas. Elsevier PracticeUpdate Website, 2021.
4. Mehta MP, Kotecha RR, Tom MC. A commentary on: Memory in Low-Grade Glioma Patients Treated With Radiotherapy or Temozolomide. A Correlative Analysis of EORTC Study 22033-26033. Elsevier PracticeUpdate Website, 2021.
5. Mehta MP, Kotecha RR, Tom MC. A commentary on: Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain. Elsevier PracticeUpdate Website, 2021.
6. Mehta MP, Kotecha RR, Tom MC. A commentary on: Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases. Elsevier PracticeUpdate Website, 2021.
7. Mehta MP, Kotecha RR, Tom MC. A commentary on: A Prospective Phase II Randomized Trial of Proton Radiotherapy vs Intensity Modulated Radiotherapy for Patients With Newly Diagnosed Glioblastoma. Elsevier PracticeUpdate Website, 2021.